EUVIMEDEUVIMED entdecken
Open Access · CC0

Benidipine impairs innate immunity converting sublethal to lethal infections in a murine model of spotted fever rickettsiosis

Andrés F Londoño iD, Jennifer M Farner, Marlon Dillon, Dennis J Grab, Yuri Kim, Diana G Scorpio, J Stephen Dumler iD

PLOS Neglected Tropical Diseases · 26.02.2024 · 18 (2) · e0011993

DOI: 10.1371/journal.pntd.0011993 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 26.02.2024. Verfasst von Andrés F Londoño und 6 weiteren Autor:innen. Beteiligte Einrichtung: Henry M. Jackson Foundation for Advancement of Military Medicine, Bethesda, Maryland, United States of America. Hauptthemen laut MEDLINE: Rickettsia Infections, Rickettsia, Spotted Fever Group Rickettsiosis, Dihydropyridines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIH HHS, NIAID NIH HHS, Congressionally Directed Medical Research Programs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spotted fever group rickettsiae are tick-borne obligate intracellular bacteria that infect microvascular endothelial cells. Humans and mammalian infection results in endothelial cell barrier dysfunction and increased vascular permeability. We previously demonstrated that treatment of Rickettsia parkeri- infected cells with the calcium channel blocker benidipine significantly delayed vascular barrier permeability. Thus, we hypothesized that benidipine, known to be safe and effective for other clinical processes, could reduce rickettsia-induced vascular permeability in vivo in an animal model of spotted fever rickettsiosis. Based on liver, lung and brain vascular FITC-dextran extravasation studies, benidipine did not reliably impact vascular permeability. However, it precipitated a deleterious effect on responses to control sublethal R . parkeri infection. Animals treated with benidipine alone had no clinical signs or changes in histopathology and splenic immune cell distributions. Benidipine-treated infected animals had marked increases in tissue and blood bacterial loads, more extensive inflammatory histopathologic injury, and changes in splenic architecture and immune cell distributions potentially reflecting diminished Ca 2+ signaling, reduced innate immune cell activation, and loss of rickettsial propagation control. Impaired T cell activation by R . parkeri antigen in the presence of benidipine was confirmed in vitro with the use of NKT cell hybridomas. The unexpected findings stand in stark contrast to recent discussions of the benefits of calcium channel blockers for viral infections and chronic infectious or inflammatory diseases. A role for calcium channel blockers in exacerbation of human rickettsiosis and acute inflammatory infections should be evaluated by a retrospective review of patient’s outcomes and medications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rickettsia InfectionsRickettsiaSpotted Fever Group RickettsiosisDihydropyridinesHumansMiceAnimalsDisease Models, AnimalCalcium Channel BlockersEndothelial CellsImmunity, InnateMammals

Substanzen

benidipineCalcium Channel BlockersDihydropyridines

Autor:innen und Institutionen

  • Henry M. Jackson Foundation for Advancement of Military Medicine, Bethesda, Maryland, United States of America.
  • Department of Pathology, School of Medicine, Uniformed Services University, Bethesda, Maryland, United States of America.
  • Emerging Infectious Disease Graduate Program, School of Medicine, Uniformed Services University, Bethesda, Maryland, United States of America.
  • Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.

ORCID-Profile: Andrés F Londoño, J Stephen Dumler

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • Congressionally Directed Medical Research Programs
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Londoño, A. F., Farner, J. M., Dillon, M., Grab, D. J., Kim, Y., Scorpio, D. G., & Dumler, J. S. (2024). Benidipine impairs innate immunity converting sublethal to lethal infections in a murine model of spotted fever rickettsiosis. PLOS Neglected Tropical Diseases, 18(2), e0011993. https://doi.org/10.1371/journal.pntd.0011993

Vancouver

Londoño AF, Farner JM, Dillon M, Grab DJ, Kim Y, Scorpio DG, et al. Benidipine impairs innate immunity converting sublethal to lethal infections in a murine model of spotted fever rickettsiosis. PLOS Neglected Tropical Diseases. 2024;18(2):e0011993. doi:10.1371/journal.pntd.0011993

BibTeX
@article{Londoo2024,
  author = {Londoño, Andrés F and Farner, Jennifer M and Dillon, Marlon and Grab, Dennis J and Kim, Yuri and Scorpio, Diana G and Dumler, J Stephen},
  title = {Benidipine impairs innate immunity converting sublethal to lethal infections in a murine model of spotted fever rickettsiosis},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  volume = {18},
  number = {2},
  pages = {e0011993},
  doi = {10.1371/journal.pntd.0011993}
}
Kostenlos starten →